UBS Group »

Trinity Biotech shares owned by UBS Group

Quarter-by-quarter ownership of Trinity Biotech (TRIB) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Trinity Biotech

Tip: Access up to 7 years of quarterly data

All positions including Trinity Biotech held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trinity Biotech by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $52 51 1.04
2024-12-31 $9.3k 11k 0.88
2024-03-31 $11k 5.2k 2.04

More positions owned by UBS Group

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Ubs Group SHS (UBS)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A (V)

View all positions for UBS Group

Top funds holding Trinity Biotech

Perceptive Advisors
Hunter Associates
Renaissance Technologies
Citadel Advisors
Susquehanna International
Captrust Financial Advisors
Moss Adams Wealth Advisors
Two Sigma Investments
Cambridge Investment Research Advisors
Raymond James Financial
Becker Capital Management
Geode Capital Management
Commonwealth Equity Services
Two Sigma Securities
Williams & Novak

View all funds holding Trinity Biotech